Novartis also reiterated its focused approach to capital allocation, including the ongoing $15 billion share buy-back announced in July 2023 and to continue paying an annual dividend, up from the CHF …
Read Full Story at source (may require registration)
Hereby we publish the opinion of the Supervisory Board of Enefit Green AS on the…
Bitcoin is now more correlated with gold, which reached another all-time high, while the US…
If BTC can break through the resistance level of $86,000, it may target higher levels,…
NEW YORK, April 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights…
Global Times: Feng Jicai leads efforts to preserve China's cultural heritage through art, literature, and…
Hanover, MA , April 20, 2025 (GLOBE NEWSWIRE) -- Boston Hemp Inc., a leader in…
This website uses cookies.